Currently, the share price for Bliss GVS Pharma Ltd. is delayed. Login to view live prices.
Bliss GVS Pharma Ltd.
0.00 (0.00%) 1D
- Prev. Close141.25
- Upper Circuit155.35
- Lower Circuit127.15
Bliss GVS Pharma Ltd.'s Info & Management
Bliss GVS Pharma Ltd (BGPL) is a fast growing pharmaceutical company with a track record of developing, manufacturing and distributing high-quality pharmaceutical formulations for the global market at competitive rates.
- Chief Financial OfficerDeepak Sawant
- Company SecretaryAditi Bhatt
FAQs on Bliss GVS Pharma Ltd.
What is the share price of Bliss GVS Pharma Ltd.?
Bliss GVS Pharma Ltd. share price is ₹140.60 as of November 30, 2023, 10:14 AM. Share prices change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the market cap of Bliss GVS Pharma Ltd.?
Market cap is calculated by multiplying the company's share price with the total outstanding shares. The market cap of Bliss GVS Pharma Ltd. is ₹1,479 Cr as of November 30, 2023.
What is the PE ratio of Bliss GVS Pharma Ltd.?
The PE ratio of Bliss GVS Pharma Ltd. is 16.70 as of November 30, 2023.The PE ratio measures the current share price relative to the earnings of the company for past 12 months (as of last reported period).
What is the PB ratio of Bliss GVS Pharma Ltd.?
The trailing twelve month (TTM) PB ratio of Bliss GVS Pharma Ltd. is 1.60 as of November 30, 2023. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Bliss GVS Pharma Ltd.?
Upper Circuit is ₹155.35. Lower Circuit is ₹127.15.
What is the ROE of Bliss GVS Pharma Ltd.?
Bliss GVS Pharma Ltd. reported an ROE of 8.01% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Bliss GVS Pharma Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Bliss GVS Pharma Ltd., Promoter held 35.1%, the FII held 16.3%, DII held 6.6% and the public held 42% of the total shares.
How to buy Bliss GVS Pharma Ltd. Share?
What is the fair value of Bliss GVS Pharma Ltd.?
Fair value in investing refers to the estimated potential price of the business. The market (or exchange) is expected to determine the fair value of listed companies by the way of demand and supply. To determine the fair value of Bliss GVS Pharma Ltd. as per market, look at the current bid and ask prices during the trading hours.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.